KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizationCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in IntangiblesChange in IntangiblesDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Amortization - Deferred ChargesCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Gsk (GSK) Shares Issued (2016 - 2026)

Gsk has reported Shares Issued over the past 18 years, most recently at $10.8 million for Q1 2026.

  • For Q1 2026, Shares Issued fell 28.64% year-over-year to $10.8 million; the TTM value through Mar 2026 reached $51.6 million, down 29.78%, while the annual FY2025 figure was $20.0 million, 22.27% down from the prior year.
  • Shares Issued for Q1 2026 was $10.8 million at Gsk, up from $1.3 million in the prior quarter.
  • Over five years, Shares Issued peaked at $24.4 million in Q4 2024 and troughed at $1.3 million in Q4 2025.
  • A 5-year average of $15.7 million and a median of $15.1 million in 2025 define the central range for Shares Issued.
  • Biggest five-year swings in Shares Issued: skyrocketed 134.81% in 2024 and later crashed 94.55% in 2025.
  • Year by year, Shares Issued stood at $23.5 million in 2022, then crashed by 52.38% to $11.2 million in 2023, then soared by 118.31% to $24.4 million in 2024, then crashed by 94.55% to $1.3 million in 2025, then skyrocketed by 710.83% to $10.8 million in 2026.
  • Business Quant data shows Shares Issued for GSK at $10.8 million in Q1 2026, $1.3 million in Q4 2025, and $15.1 million in Q1 2025.